EEG-synchronizing effect of γ-hydroxybutyrate and 1-hydroxy-3-amino-pyrrolidone-2 (HA-966) in relation to dopaminergic brain function
- 31 August 1975
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 14 (8), 591-599
- https://doi.org/10.1016/0028-3908(75)90126-4
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- A method and its pharmacological application to determine the duration of arousal pattern based on amplitude changes of EEG signals in ratsCellular and Molecular Life Sciences, 1974
- Antagonism of neuronal excitation by 1-hydroxy-3-aminopyrrolidone-2Brain Research, 1973
- Effects of drugs influencing monoamine mechanisms on the increase in brain dopamine produced by axotomy or treatment with gammahydroxybutyric acidNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1973
- The effect of sodium γ‐hydroxybutyrate on the metabolism of dopamine in the brainBritish Journal of Pharmacology, 1972
- Evidence for a receptor-mediated feedback control of striatal tyrosine hydroxylase activityJournal of Pharmacy and Pharmacology, 1972
- 1‐Hydroxy‐3‐amino‐pyrrolidone‐2 (HA‐966): a new GABA‐like compound, with potential use in extrapyramidal diseasesBritish Journal of Pharmacology, 1971
- The effect of surgical lesions to frontal cortex and substantia nigra on amphetamine responses in ratsBrain Research, 1971
- SELECTIVE INCREASE OF BRAIN DOPAMINE INDUCED BY γ‐HYDROXYBUTYRATE: STUDY OF THE MECHANISM OF ACTION*Journal of Neurochemistry, 1968
- Decrease of cerebral 5-hydroxytryptamine by 3,4-dihydroxyphenylalanine after inhibition of extracerebral decarboxylaseJournal of Pharmacy and Pharmacology, 1968
- Histochemical amd biochemical effects of diethyldithiocarbamate on tissue catecholaminesJournal of Pharmacy and Pharmacology, 1966